• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症精准医疗的综合临床与基因组信息系统。

An integrated clinical and genomic information system for cancer precision medicine.

作者信息

Jang Yeongjun, Choi Taekjin, Kim Jongho, Park Jisub, Seo Jihae, Kim Sangok, Kwon Yeajee, Lee Seungjae, Lee Sanghyuk

机构信息

Ewha Research Center for Systems Biology (ERCSB), Ewha Womans University, Seoul, Korea.

Interdisciplinary Program in Bioinformatics, College of Natural Science, Seoul National University, Seoul, Korea.

出版信息

BMC Med Genomics. 2018 Apr 20;11(Suppl 2):34. doi: 10.1186/s12920-018-0347-9.

DOI:10.1186/s12920-018-0347-9
PMID:29697362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918454/
Abstract

BACKGROUND

Increasing affordability of next-generation sequencing (NGS) has created an opportunity for realizing genomically-informed personalized cancer therapy as a path to precision oncology. However, the complex nature of genomic information presents a huge challenge for clinicians in interpreting the patient's genomic alterations and selecting the optimum approved or investigational therapy. An elaborate and practical information system is urgently needed to support clinical decision as well as to test clinical hypotheses quickly.

RESULTS

Here, we present an integrated clinical and genomic information system (CGIS) based on NGS data analyses. Major components include modules for handling clinical data, NGS data processing, variant annotation and prioritization, drug-target-pathway analysis, and population cohort explorer. We built a comprehensive knowledgebase of genes, variants, drugs by collecting annotated information from public and in-house resources. Structured reports for molecular pathology are generated using standardized terminology in order to help clinicians interpret genomic variants and utilize them for targeted cancer therapy. We also implemented many features useful for testing hypotheses to develop prognostic markers from mutation and gene expression data.

CONCLUSIONS

Our CGIS software is an attempt to provide useful information for both clinicians and scientists who want to explore genomic information for precision oncology.

摘要

背景

下一代测序(NGS)成本的不断降低为实现基于基因组信息的个性化癌症治疗创造了机会,这是精准肿瘤学的一条途径。然而,基因组信息的复杂性给临床医生解读患者的基因组改变并选择最佳的获批或研究性治疗带来了巨大挑战。迫切需要一个精心设计且实用的信息系统来支持临床决策,并快速验证临床假设。

结果

在此,我们展示了一个基于NGS数据分析的临床与基因组综合信息系统(CGIS)。主要组件包括处理临床数据、NGS数据处理、变异注释与优先级排序、药物 - 靶点 - 通路分析以及人群队列浏览器的模块。我们通过从公共和内部资源收集注释信息,构建了一个关于基因、变异、药物的综合知识库。使用标准化术语生成分子病理学的结构化报告,以帮助临床医生解读基因组变异并将其用于靶向癌症治疗。我们还实现了许多有助于从突变和基因表达数据中验证假设以开发预后标志物的功能。

结论

我们的CGIS软件旨在为希望探索基因组信息用于精准肿瘤学的临床医生和科学家提供有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/49c86977bd45/12920_2018_347_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/90093c606300/12920_2018_347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/d489c1c7a133/12920_2018_347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/a83ebf6a1c1b/12920_2018_347_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/49c86977bd45/12920_2018_347_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/90093c606300/12920_2018_347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/d489c1c7a133/12920_2018_347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/a83ebf6a1c1b/12920_2018_347_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5a/5918454/49c86977bd45/12920_2018_347_Fig4_HTML.jpg

相似文献

1
An integrated clinical and genomic information system for cancer precision medicine.用于癌症精准医疗的综合临床与基因组信息系统。
BMC Med Genomics. 2018 Apr 20;11(Suppl 2):34. doi: 10.1186/s12920-018-0347-9.
2
A decision support framework for genomically informed investigational cancer therapy.用于基于基因组信息的癌症研究性治疗的决策支持框架。
J Natl Cancer Inst. 2015 Apr 11;107(7). doi: 10.1093/jnci/djv098. Print 2015 Jul.
3
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.癌症中的下一代测序:精准癌症医学的机遇与挑战
Scand J Clin Lab Invest Suppl. 2016;245:S84-91. doi: 10.1080/00365513.2016.1210331. Epub 2016 Aug 17.
4
From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.从体细胞变异到精准肿瘤学:分子肿瘤委员会中基于证据的治疗选择报告。
Genome Med. 2018 Mar 15;10(1):18. doi: 10.1186/s13073-018-0529-2.
5
An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.一个用于报告来自配对肿瘤/正常基因组和转录组测序数据的临床相关生物标志物的综合框架,以支持个性化医学中的临床试验。
Pac Symp Biocomput. 2015:56-67.
6
AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.美国癌症研究协会精准医学系列:整合临床基因组学与癌症治疗会议亮点
Mutat Res. 2015 Dec;782:44-51. doi: 10.1016/j.mrfmmm.2015.10.005. Epub 2015 Nov 3.
7
Enabling Precision Oncology Through Precision Diagnostics.通过精准诊断实现精准肿瘤学。
Annu Rev Pathol. 2020 Jan 24;15:97-121. doi: 10.1146/annurev-pathmechdis-012418-012735.
8
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.精准肿瘤学和基于基因组学的放射治疗:来自美国放射肿瘤学会/美国医学物理学家协会/美国国立癌症研究所精准医学会议的报告。
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):274-284. doi: 10.1016/j.ijrobp.2017.05.044. Epub 2017 Jun 9.
9
Physician interpretation of genomic test results and treatment selection.医生对基因组检测结果的解读和治疗选择。
Cancer. 2018 Mar 1;124(5):966-972. doi: 10.1002/cncr.31112. Epub 2017 Nov 22.
10
Genomics-Enabled Precision Medicine for Cancer.基因组学助力的癌症精准医学
Cancer Treat Res. 2019;178:137-169. doi: 10.1007/978-3-030-16391-4_5.

引用本文的文献

1
How artificial intelligence is transforming nephrology.人工智能如何改变肾脏病学
BMC Nephrol. 2024 Aug 27;25(1):276. doi: 10.1186/s12882-024-03724-6.
2
Integrated multi-omics with machine learning to uncover the intricacies of kidney disease.运用整合多组学和机器学习技术揭示肾脏疾病的复杂性。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae364.
3
A comprehensive database for integrated analysis of omics data in autoimmune diseases.一个用于自身免疫性疾病组学数据综合分析的综合数据库。

本文引用的文献

1
OncoKB: A Precision Oncology Knowledge Base.OncoKB:一个精准肿瘤知识库。
JCO Precis Oncol. 2017 Jul;2017. doi: 10.1200/PO.17.00011. Epub 2017 May 16.
2
CVE: an R package for interactive variant prioritisation in precision oncology.CVE:一个用于精准肿瘤学中交互式变异优先级排序的R包。
BMC Med Genomics. 2017 May 25;10(1):37. doi: 10.1186/s12920-017-0261-6.
3
PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.PathOS:临床诊断实验室中用于报告癌症高通量测序结果的决策支持系统。
BMC Bioinformatics. 2021 Jun 24;22(1):343. doi: 10.1186/s12859-021-04268-4.
4
Knowledge bases and software support for variant interpretation in precision oncology.精准肿瘤学中变体解释的知识库和软件支持。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab134.
5
Big Data Approaches in Heart Failure Research.大数据方法在心力衰竭研究中的应用。
Curr Heart Fail Rep. 2020 Oct;17(5):213-224. doi: 10.1007/s11897-020-00469-9.
6
[Detection and interpretation of somatic variants in molecular pathology].[分子病理学中体细胞变异的检测与解读]
Pathologe. 2019 May;40(3):243-249. doi: 10.1007/s00292-019-0603-6.
Genome Med. 2017 Apr 24;9(1):38. doi: 10.1186/s13073-017-0427-z.
4
Implementing Genome-Driven Oncology.实施基因组驱动的肿瘤学。
Cell. 2017 Feb 9;168(4):584-599. doi: 10.1016/j.cell.2016.12.015.
5
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.在一项前瞻性癌症精准医学研究中,对体细胞和种系全外显子测序数据赋予临床意义。
Genet Med. 2017 Jul;19(7):787-795. doi: 10.1038/gim.2016.191. Epub 2017 Jan 26.
6
COSMIC: somatic cancer genetics at high-resolution.COSMIC:高分辨率体细胞癌遗传学
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783. doi: 10.1093/nar/gkw1121. Epub 2016 Nov 28.
7
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update.用于可访问、可重复和协作式生物医学分析的Galaxy平台:2016年更新
Nucleic Acids Res. 2016 Jul 8;44(W1):W3-W10. doi: 10.1093/nar/gkw343. Epub 2016 May 2.
8
The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome.《少有人走的路:一种在我的癌症基因组中提供精准肿瘤医学信息的途径导向方法》。
Transl Oncol. 2016 Apr;9(2):163-165. doi: 10.1016/j.tranon.2016.03.001.
9
The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform.在正确的时间为正确的患者使用正确的药物:MD安德森精准肿瘤学决策支持平台。
Drug Discov Today. 2015 Dec;20(12):1433-8. doi: 10.1016/j.drudis.2015.05.013. Epub 2015 Jul 3.
10
Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations.基于基因组改变的互斥性对癌症驱动信号通路进行系统鉴定。
Genome Biol. 2015 Feb 26;16(1):45. doi: 10.1186/s13059-015-0612-6.